INFLUENCE OF THE BIOFLAVONOID RUTOSIDE ON DEVELOPMENT OF DIABETIC CATARACT IN AN EXPERIMENT
DOI:
https://doi.org/10.31288/oftalmolzh201316265Keywords:
експериментальний діабет, діабетична катаракта, профілактика, рутозидAbstract
In-process cited data experimental research. Under a supervision there were three groups of experimental animals — rabbit. 1 group — control, 2 a group is animals with experimental streptozotocin diabetes, 3 a group is animals with experimental streptozotocin diabetes, at that the bioflavonoid of rutoside was plugged in the ration of feed. Studied influence of rutoside on frequency of origin and speed of development of diabetic cataract. The expressed is set anticataract action of rutoside since 8 week of experiment.
References
1. Воскресенская Л. К. Патогенез и лечение старческой и диабетической катаракты: автореф. дисс. ... докт. мед. наук: 14.00.16, 14.00.08 «Российский Университет дружбы народов» - М., 1993. - 32 с.
2. Костровська К. О. Ефективність хірургічного лікування катаракти у хворих на цукровий діабет: автореф. дис. ... канд. мед. наук: 14.01.18 «ДУ Інститут очних хвороб і тканинної терапії ім В. П. Філатова АМН України» - Одеса, 2010. - 18 с.
3. Леус Н. Ф., Гиржева А. В., Журавок Ю. А. Влияние биофлавоноидов (кверцетина и рутина) на развитие патологических изменений в хрусталике при моделировании возрастной катаракты // Офтальмол. журн. - 2010. - № 6. - С. 60- 65.
4. Мальцев Э. В., Багиров Н. А. Эпидемиология катаракт // Офтальмол. журн. - 2001. - № 6. - С. 45- 49.
5. Науменко В. Г. Патогенетична терапія ускладнень цукрового діабету // Междунар. Эндокринол. Журн. - 2006. - № 1. - Т. 3. - С. 71-77.
6. Реброва О. Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA / О. Ю. Реброва. - М.: Медиа Сфера, 2002. - С. 312.
7. Afanas'ev I. B., Dorozhko A. I., Brodskii A. V. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation // Biochem. Pharmacol. - 1989. - Vol. 38. - № 11. - P. 1763-1769. https://doi.org/10.1016/0006-2952(89)90410-3
8. Ahmed N., Naqvi F. N., Shafiq F. Lipid peroxidation and serum antioxidant enzymes in patients with type 2 diabetes mellitus / N. Ahmed, F. N. // Ann. N Y Acad. Sci. - 2006. - Vol. 1084. - P. 481- 489.https://doi.org/10.1196/annals.1372.022
9. Biswas S., Harris F. Singh J. Role of calpains in diabetes mellitus-induced cataractogenesis: a mini review // Moll. Cell Biochem. - 2004. - Vol. 261. - P. 151-159.https://doi.org/10.1023/B:MCBI.0000028750.78760.6f
10. Boyle S. P., Dobson V. L., Duthie S. J. Biovailability and efficiency of rutin as an antioxidant: a human supplementation study // Eur. J. Clin. Nutr. - 2000. - Vol. 54. - P. 774-782.https://doi.org/10.1038/sj.ejcn.1601090
11. Cervantes-Laurean D., Schramm D. D., Jacobson E. L. Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites // J. Nutr. Biochem. - 2006. - Vol. 17. - P. 531- 540.https://doi.org/10.1016/j.jnutbio.2005.10.002
12. Datta V., Swift P. G. F., Woodruff G. H. A. Metabolic cataracts in newly diagnosed diabetes // Arch. Disease Child-hood. - 1997. - Vol. 76. - P. 118-120.https://doi.org/10.1136/adc.76.2.118
13. Donma O., Yorulmaz E., Pekel H., Suyugul N. Blood and lens lipid peroxidation and antioxidant status in normal in-dividuals, senile and diabetic cataractous patients // Curr. Eye Res. - 2002. - V. 25. - P. 9-16.https://doi.org/10.1076/ceyr.25.1.9.9960
14. Eman M. A., Eman S. M. The role of alpha-lipoic acid in streptozotocin-induced diabetic cataract // Romanian J. Biophys. - 2011. - Vol. 21. - P. 73- 83.
15. Hashim Z., Zarina S. Antioxidant markers in human senile and diabetic cataractous lenses // J. Coll. Physic. Surg. Pak. - 2006. - Vol. 16. - № 10. - P. 637- 640.
16. Hedge K. R., Varma S. D. Cataracts in experimentally dia-betic mouse: morphological and apoptotic chanes // Diabetes, Obesity and Metabolism. - 2005. - V. 7. - № 2. - P. 200-204.https://doi.org/10.1111/j.1463-1326.2004.00368.x
17. Isai M., Sakthivel M., Ramesh E., Thomas P. A. Pre-vention of selenite-induced cataractogenesis by rutin in Wistar rats // Mol. Vis. - 2009. - Vol. 15. - P. 25702577.
18. Jaganath I. B., Mullen W., Edwards C. A. The relative contribution of the small and large intestine to the absorption and metabolism of rutin in man // Free Rad. Res. - 2006. - Vol. 40. - № 10. - P. 1035- 1046.https://doi.org/10.1080/10715760600771400
19. Je H. D., Shin C. Y., Park S. Y. Combination of vitamin C and rutin on neuropathy and lung damage of diabetes mellitus rats // Arch. Pharm. Res. - 2002. - Vol. 25. - № 2. - P. 184- 190.https://doi.org/10.1007/BF02976561
20. Kamalakkannan N., Prince S. M. The influence of rutin on the extracellular matrix in streptozotocin-induced diabetic rat kidney // J. Pharm. Pharmacol. - 2006. - Vol. 58. - № 8. - P. 1091- 1098.https://doi.org/10.1211/jpp.58.8.0010
21. Kyselova Z., Stefec M., Bauer V. Pharmacological pre-vention of diabetic cataract // J. Diabet. Complicat. - 2004. - Vol. 18. - P. 129- 140.https://doi.org/10.1016/S1056-8727(03)00009-6
22. Meyer C. H., Sekundo W. Nutritional supplementation to prevent cataract formation // Dev. Ophthalmol. - 2005. - V. 38. - P. 103-119.https://doi.org/10.1159/000082771
23. Nagasawa T., Tabata N., Ito Y. Dietary G-rutin suppresses glycation in tissue proteins of streptozotocin-induced diabetic rats // Mol. Cell. Biochem. - 2003. - Vol. 252. - P. 141-147.https://doi.org/10.1023/A:1025563519088
24. Obrosova I. G., Chung S. S. M., Kador P. F. Diabetic cataracts: mechanisms and management // Diabetes. Metab. Res. Rev. - 2010. - Vol. 26. - P. 172- 180.https://doi.org/10.1002/dmrr.1075
25. Pashikanti S., Alba D. R., Boissonneault G. A. Rutin metabolites: novel inhibitors of nonoxidative advanced gly-cation end products // Free Rad. Biol. Med. - 2010. - Vol. 48. - P. 656- 663.https://doi.org/10.1016/j.freeradbiomed.2009.11.019
26. Prince S. M., Kamalakkannan N. Rutin improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes // J. Biochem. Mol. Toxicol. - 2006. - Vol. 20. - № 2. - P. 96- 102.https://doi.org/10.1002/jbt.20117
27. Toh T., Morton J., Coxon J., Elder M. J. Medical treat-ment of cataract // Clin. Experiment Ophthalmol. -2007. - V. 35. - № 7. - P. 664- 671.https://doi.org/10.1111/j.1442-9071.2007.01559.x
28. Zhang S., Chai F. Y. Effects of N-acetylcysteine and glutathione ethyl ester drops on streptozotocin-induced diabetic cataract // Mol. Vis. - 2008. - Vol. 14. - P. 862- 870.
Downloads
Published
Issue
Section
License
Copyright (c) 2013 K. Pavlyuchenko, S. Mogilevskyy, K. Gudzenko
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
